Amello Jason - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 28, 2023, Amello Jason's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Financial Officer), and currently has 202,009 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CADL insiders.
Data Source: SEC.
Amello Jason - Insider Non-Derivative Transactions of CADL Common Stock
Amello Jason - Insider Non-Derivative Transactions at CADL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 29, 2023 | F -- (Common Stock) | 20153 | 0.9 | 202009 |
| Nov 27, 2023 | Acquisition -- (Common Stock) | 125717 | 0 | 222162 |